AstraZeneca is a posterchild of the UK stock market as Britain's largest listed company. So it's telling that it too is warning that there is a risk a trade war could damage both its bottom line and its drug development Bloomberg's Caroline Hepker and Stephen Carroll spoke to the pharmaceutical giant's CFO Aradhana Sarin as the company posted its first quarter earnings figures.

Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks
09:04

Jim Chanos Talks SpaceX IPO
13:48

US Energy Secretary Chris Wright Talks Oil Flows Through Strait of Hormuz
26:52